Michael Barbella, Managing Editor06.06.24
Enovis Corporation has opened a new facility in Portugal to enhance its digital prowess and improve workflows.
Located in Libson, the Enovis Global Business Technology Centre will serve as a hub for the company’s international Prevention & Recovery (P&R) group and help develop automation and digital capabilities, as well as integrate artificial intelligence to optimize workflows.
The Centre can house 100 employees, and Enovis plans to recruit 40 of those team members by the end of the year to serve end-to-end finance and business operations while also acting as a digital platform for supply chain, sales, and customer experience applications. Other career opportunities are under evaluation. At launch, the Centre is serving most European countries but will eventually also assist customers in Canada and beyond. Led by Elisabeth Drouffe, an experienced global shared services leader, the Centre will also act as an interactive meeting space for Kaizens, trainings, and international Enovis events.
“With our rapid growth, diverse businesses and strong innovation pipeline, we knew it was time to establish a business technology centre in a central location that could scale with us,” Enovis International P&R President Cathal O’Donnell said. “Lisbon was the perfect choice with its vibrant tech scene, multicultural skilled talent, and great quality of life.”
With 20 acquisitions since 2019, Enovis has been rapidly expanding globally. The company’s investment in regional centers of excellence like the Enovis Global Business Centre will create strategic advantage, enable further globalization in key innovation areas, and ultimately help Enovis continue to develop medical technology that improves patient outcomes.
“We are excited to welcome Enovis to Lisbon,” stated Filipe Santos Costa, chairman/CEO of AICEP, Portugal’s trade and investment agency. “Portugal offers a robust digital infrastructure to thrive and innovate on a global scale and this new foreign investment is another good example of the country's position as a tech hub in Europe.”
Enovis Corporation is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The Wilmington, Del.-based company’s products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. Its common stock is listed in the United States on the New York Stock Exchange under the symbol ENOV.
Located in Libson, the Enovis Global Business Technology Centre will serve as a hub for the company’s international Prevention & Recovery (P&R) group and help develop automation and digital capabilities, as well as integrate artificial intelligence to optimize workflows.
The Centre can house 100 employees, and Enovis plans to recruit 40 of those team members by the end of the year to serve end-to-end finance and business operations while also acting as a digital platform for supply chain, sales, and customer experience applications. Other career opportunities are under evaluation. At launch, the Centre is serving most European countries but will eventually also assist customers in Canada and beyond. Led by Elisabeth Drouffe, an experienced global shared services leader, the Centre will also act as an interactive meeting space for Kaizens, trainings, and international Enovis events.
“With our rapid growth, diverse businesses and strong innovation pipeline, we knew it was time to establish a business technology centre in a central location that could scale with us,” Enovis International P&R President Cathal O’Donnell said. “Lisbon was the perfect choice with its vibrant tech scene, multicultural skilled talent, and great quality of life.”
With 20 acquisitions since 2019, Enovis has been rapidly expanding globally. The company’s investment in regional centers of excellence like the Enovis Global Business Centre will create strategic advantage, enable further globalization in key innovation areas, and ultimately help Enovis continue to develop medical technology that improves patient outcomes.
“We are excited to welcome Enovis to Lisbon,” stated Filipe Santos Costa, chairman/CEO of AICEP, Portugal’s trade and investment agency. “Portugal offers a robust digital infrastructure to thrive and innovate on a global scale and this new foreign investment is another good example of the country's position as a tech hub in Europe.”
Enovis Corporation is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The Wilmington, Del.-based company’s products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. Its common stock is listed in the United States on the New York Stock Exchange under the symbol ENOV.